According to Sumitomo Pharma
's latest financial reports the company has $0.30 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-03-31 | $1.22 B | -37.16% |
2022-03-31 | $1.95 B | -3.36% |
2021-03-31 | $2.02 B | 67.59% |
2020-03-31 | $1.20 B | -25.99% |
2019-03-31 | $1.63 B | 2.1% |
2018-03-31 | $1.59 B | 45.06% |
2017-03-31 | $1.10 B | -33.09% |
2016-03-31 | $1.64 B | 39.26% |
2015-03-31 | $1.18 B | 16.15% |
2014-03-31 | $1.01 B | -8.82% |
2013-03-31 | $1.11 B | -17.48% |
2012-03-31 | $1.35 B | 6.23% |
2011-03-31 | $1.27 B | 83.15% |
2010-03-31 | $0.69 B | 21.78% |
2009-03-31 | $0.57 B | -2.17% |
2008-03-31 | $0.58 B | -17.94% |
2007-03-31 | $0.71 B | 12.65% |
2006-03-31 | $0.63 B | 70.32% |
2005-03-31 | $0.37 B |